424 Capital Exits Reverba in Sale With Undisclosed Buyer and Terms
424 Capital has exited Reverba through a strategic sale, with the buyer and terms undisclosed, ending a 2021 partnership that broadened its patient-engagement platform.
Topic
Topic
424 Capital has exited Reverba through a strategic sale, with the buyer and terms undisclosed, ending a 2021 partnership that broadened its patient-engagement platform.